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Previous investigations have disclosed that normal allogeneie bone marrow cells can 
transfer antibody-forming capacity to irradiated rabbits (1-5).  On the other hand, 
"primed" bone marrow (bone marrow obtained from a donor rabbit 24 hr following 
intravenous  administration  of  the  specific  antigen)  could  not  transfer  antibody- 
forming capacity to the antigen with which the marrow donor had been immunized, 
but could transfer immunocompetence to other antigens (3, 4). It was also demon- 
strated that the antibody-forming cell in the marrow recipient is of host, not donor, 
origin  (5),  thus  supporting  the  conclusion  that  the  immunoeompetent cell  in  the 
bone marrow is the antigen-reactive cell and that the bone marrow does not contain 
any antibody-forming cells  (4--7). Furthermore, it was demonstrated that antigen- 
reactive cells, isolated by passage of the normal bone marrow cell suspension  through 
an antigen-sensitized  glass bead colnmn, followed by elution of retained cells from 
the column (eluate), could transfer antibody-forming capacity to an irradiated rabbit, 
but only toward the antigen used to sensitize  the glass beads (2).  In contrast,  the 
cells which passed through the antigen-sensitized  glass bead column (effluent) lost the 
capacity to transfer immtmoeompetence with respect to the antigen used to sensitize 
the beads, but not with respect to other non-cross-reacting antigens (2). 
These findings suggested a means of indentifying which of the cell types con- 
cerned with the mediation of the humoral immune response in the rabbit--the 
antigen-reactive cell or  the  antibody-forming ceil--is the  tolerant cell in  the 
immunologicaily tolerant rabbit. As shown below, it would appear that the anti- 
gen-reactive cell is the one which is unresponsive in the latter animal. 
Materials and Methods 
New Zealand  white rabbits  were used  throughout  this  study.  The  antigens  used  were 
human serum albumin (HSA) (Ityland Laboratories, Los Angeles, Calif.) and bovine gamma 
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globulin (BGG)  (Pentex, Inc., Kankakee, Ill.). Solutions of these antigens, in various con- 
centratiuns, were prepared in Medium 199 (Med-199) (Microbiological Associates, Bethesda, 
Md.)  and sterilized by Seitz filtration. 
Normal bone marrow refers to that obtained from an adult, ,nimmunized rabbit. Primed 
bone marrow refers to marrow obtained from a rabbit immunized intravenously 24 hr prior to 
sacrifice. Normal and primed rabbit bone marrow were obtained as previously described  (2, 
4). The femur and tibia were split bilaterally with a  bone cutter, and the bone marrow was 
transferred to sterile plastic tubes (Faicon Plastics, Los Angeles, Calif.), each containing ap- 
proximately 5 ml normal rabbit serum  (NRS)  (Microbiological Associates, Bethesda, Md.). 
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FIG.  1. Protocol of procedures followed for the demonstration of the antigen-reactive cell 
as the tolerant cell in the immunologically tolerant rabbit. 
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The tubes were vigorously shaken for several minutes and centrifuged at 600 rpm for 10 rain. 
The fatty supernatants were decanted, and the cells were suspended in Med-199 and cen- 
trifuged once more at 600 rpm for 10 min. The cells were then resuspended in Meal-199 con- 
raining 15% NRS to a  concentration of  i08 cells/ml. 
The protocol followed is presented in Fig. 1. Rabbits were made tolerant to HSA or B GG by 
subcutaneous injection at age 2 and 5 days with a total of 200 mg of the antigen. At 10 weeks 
of age, each of several rabbits of each litter (2-4 rabbits) was injected with 10 mg HSA or 
BGG intravenously. The humoral immune response was determined during the following 4 
wk, using the passive hemagglutination technique (8). The remaining rabbits of each litter 
(3-5 rabbits) were injected at  10 wk of age with either normal or primed allogeneic bone 
marrow. They were also injected with 25 mg HSA or BGG intravenously, and the humoral 
immune response was  followed  by  the passive  hemagglutination technique  (8).  In  other 
experiments, prospective normal recipient rabbits  were subjected to 800 R  total body irradia- 
tion, using a e°Co source, prior to being given the bone marrow cells. NABIH  I. ABDOU  AND  MAXWELL  RICtil'~R  167 
RESULTS 
A.  Immune  Response  in Normal,  Irradiated,  and Immunologically  Tolerant 
Rabbits  to lISA and BGG, and Specificity of the Antisera.--This initial series of 
experiments was carried out in order to establish the nonresponsiveness of the 
irradiated and tolerant rabbits and the non-cross-reactivity of the two antigens- 
selected for this investigation. Normal rabbits responded briskly to immuniza- 
tion with either HSA or BGG, whereas neither irradiated nor irnmunologically 
tolerant rabbits responded over a period of 40 days (Table I). Almost no cross- 
TABLE I 
Immune Response in Normal, Irradiated, and Tolerant Rabbits after Administratlon of Human 
Serum Albumin or Bo~ne Gamma Globulin 
Day of bleeding  Hemagglutination fiter* of serum samples obtained after immunization of 
after intravenous 
administration of  Normsl rabbits  Irradiated rsbbits~  Tolerant rabbits§ 
HSA or BGG 
(25 rag)  Anti-HSA  AntI-BGG  Anti-HSA  Anti-BGG  Anti-HSA  Anti-BGG 
0  0  0  0  0  0  0 
7  20  0  0  0  0  0 
14  2,560  5,120  0  0  0  0 
21  1,280  10,240  10  10  0  0 
28  640  2,560  20  0  0  0 
40  160  1,280  0  0  0  0 
* The sera in varying dilutions were incubated with HSA-sensitized or BGG-sensitized 
sheep red blood cells. The titer represents the maximum dilution of the antiserum capable of 
effecting agglutination of the antigen-sensitized red cells. Titers less than 10 are considered 
negative. 
:~ The rabbits were subjected to 800 R  total body irradiation prior to the intravenous 
administration of HSA or BGG. 
§ The rabbits were given 100 mg of HSA or BGG on days 2 and 5 of life. They were im- 
munized with HSA or BGG during the 6th wk of life. 
reactivity was  detected  between  these  two  antigen-antibody systems by the 
passive hemagglutination  technique  (Table II), the  extent of cross-reactivity 
being less than 0.1%. 
B.  Failure of  Primed Bone  Marrow  to  Transfer  Antibody-Forming Capa- 
city to Tolerant Recipients witk Respect to the Priming Antigen.--Rabbits made 
immunologically  tolerant  to  HSA  and  given  HSA-primed  allogeneic  bone 
marrow were incapable of giving an immune response following immunization 
with HSA, but produced high-titered anfisera if given normal allogeneic bone 
marrow cells and HSA (Table III). The converse situation was true of rabbits 
rendered  immunologically  tolerant  with  respect  to  BGG  and  given  BGG- 
primed  allogeneic  bone  marrow.  Immunization  of  these  rabbits  with  BGG 
failed  to  elicit  an  immune  response,  whereas  recipients  of normal  allogeneic 
bone marrow cells gave good immune responses (Table IV). 168  CELLS INVOLVED IN rM'MUNE RESPONSE. XI 
TABLE IT 
Cross-Reactivity  between Human Serum Albumin and Bovine  Gamma Globulin 
Antiserum tested* 
Hemsgglutination titers$ of antisem after incubation 
with sheep red cells sensitized with 
HSA  BGG 
Rabbit anti-HSA  16,000  40 
1,280  0 
Rabbit anti-B GG  20  25,600 
0  8,000 
* Sera obtained from rabbits immunized with 25 mg of either HSA or BGG. 
Hemaggiutination titers less than 10 are considered negative. 
TABLE III 
Immune  Response  of HSA-Tolerant  Rabbits  Given  HSA-Primed  or Normal  AUogeneic Bone 
Marrow and Immunized with HSA 
Antibody and antigen levels in sere of HSA-tolerant rabbits* 
Day of bleeding after  gtvcu bone marrow from 
bone marrow transfer 
and intravenous admin-  Normal donors  HSA-primed donors:~ 
istration of HSA 
Auti-HSA titer§  Free HSA~  Anti-HSA tlters  Free HSA 
~glr,  d  ug/ml 
--3  0  0  0  0 
5  10  ND¶  0  0.2 
8  320  ND  0  0.02 
14  1280  ND  0  0.01 
21  1280  ND  0  0.002 
28  320  ND  0  0.0003 
35  80  ND  0  0 
38** 
42  1280  ND  0  0.01 
49  2560  (2550)$$  ND  40 (0)  ND 
56  640  ND  20  ND 
* Rabbits were given 100 mg HSA on days 2 and 5 of life. They were given either normal 
or primed allogeneic bone marrow at 6 wk of age. 
Adult rabbits received 25 mg HSA intravenously 24 hr before sacrifice. 
§ The antisera were incubated with HSA-sensitized sheep red cells.  Titers below 10 are 
considered negative. 
I] Determined by the ability of the serum to inhibit the agglutination of HSA-sensitized 
sheep red cells by specific antiserum. 
¶  Not done. 
** All rabbits received 10 mg HSA intravenously. 
:~:~ Titers in parentheses after treatment of serum with 0.1 ~r 2-mercaptoetlmnol. 
The failure of the  tolerant  recipients  of primed  bone marrow  to mount  an 
immune response is reflected by the presence of free antigen in the circulation, 
which could be detected for 3-4 wk following primary immunization (Tables HI 
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It is interesting that the antibodies formed following secondary immuniza- 
tion of tolerant recipients of normal bone marrow, 38 days subsequent to pri- 
mary immunization, were  resistant  to mercaptoethanol.  011  the  other hand, 
reimmunlzation at day 38 of tolerant recipients of primed bone marrow, which 
did not produce antibodies following initial immunization, synthesized humoral 
antibodies which were mercaptoethanol-sensitive (Tables III and IV). 
TABLE IV 
Immune  Response of BGG-Tolerant Rabbits Given BGG-Primed or Normal  Allogenei¢ Bone 
Marrow and Immunized  v~tk BGG 
Antibody and antigen levels in sera of BGG-tolerant  rabbits* 
Day of bleeding after  given bone marrow from 
bone marrow transfer 
and intravenous admln-  Normal donors  BGG-prhned donors~: 
istration of BGG ~, 
Anti-BGG dter§  Free BGG~  Anti-BGG titer  Free BGG 
uglY.  ,ug/,nu~ 
--3  0  0  0  0 
5  0  0.002  0  0.1 
8  80  ND¶  0  0.06 
14  4000  ND  0  0.007 
21  1280  ND  0  0.0001 
28  640  ND  0  0 
35  160  ND  0  0 
38** 
42  8000  10  ND 
49  8000 (4000)*~  ND  640 (20)  ND 
56  2000  N-D  320  ND 
* Rabbits were given 100 nag BGG on days 2 and 5 of life. They were given either normal 
or primed allogeneic  bone marrow  at 6 wk of age. 
Adult rabbits received 25 nag BGG intravenously 24 hr before sacrifice. 
§ Titers below 10 are considered negative. 
I] Determined by the ability of the serum to inhibit the agglutination of BGG-sensitized 
sheep red cells by specific antiserum. 
¶ Not done. 
** All rabbits received 10 ing BGG intravenously. 
~: Titers in parentheses after treatment of sera with 0.1 M  2-mercaptoethanol. 
When the tolerant recipients of primed bone marrow were tested for immu- 
nological responsiveness  toward the specifie  and a  non-cross-reacting antigen, 
no immune response could be obtained with respect to the antigen used to prime 
the bone marrow donor, although a response to the non-cross-reacting antigen 
could be regularly obtained. HSA- or BGG-tolerant rabbits given normal allo- 
geneic bone marrow responded well to immunization with HSA or BGG (Tables 
V and VI). However, the HSA-tolerant recipient of HSA-primed bone marrow 
failed to respond to stimulation with HSA but responded well to BGG (Table 
V), and the BGC~tolerant recipient of BGG-primed bone marrow cells failed to 
respond to stimulation with BGG but responded well to HSA (Table VI). 170  CELLS  INVOLVED  IN  /MMUNE  RESPONSE,  XI 
TABLE  V 
Immune Response of HSA-Tolerant  Rabbits Gir~ HSA-Primed or Normal  Allogendc  Bone 
Marrow and Immunized  with liSA  and BGG: Speciaeity of the Immune Response 
Hemagglutination  titers of sera of HSA-tolerant rabbits * 
Day of bleeding after  given bone marrow from 
bone marrow transfer 
and intravenous adminis-  Normal donors  HSA-primed donors1: 
tration of HSA and BGG 
Anti-HSA  Anti-BGG  Anti-HSA  Anti-BGG 
--3  o§  o  o  o 
8  160  40  0  10 
12  640  2560  0  640 
21  1280  1280  0  640 
36  40  320  0  160 
3811 
42  2560 (1280)¶  1600 (1600)  0  1280 (1280) 
50  1280  4000  40 (10)  320 
* Rabbits were given 100 mg HSA on days 2 and 5 of life. They were given either norma 
or primed allogeneic bone marrow at 6 wk of age. 
Adult rabbits received 25 nag HSA intravenously 24 hr before sacrifice. 
§ Titers less than 10 are considered negative. 
[l All rabbits received 10 mg HSA and 10 nag BGG intravenously. 
¶  Titers in parentheses after treatment of sera with 0.1 ~s 2-naercaptoethanol. 
TABLE  VI 
Immune  Response of BGG-Tolerant Rabbits Given BGG-Primed or Normal  Allogeneie Bone 
Marrow and Immunized  with BGG and lISA: Spe~i~ity of the Immune Response 
Hemagglutination fiters of sera of BGG-tolerant  rabbits* 
Day of bleeding after  given bone marrow from 
bone marrow transfer 
and intravenous adminis-  Normal donors  BGG-primed donors~ 
tration of HSA and BGG 
Anti-HSA  Anfi-BGG  Anti-HSA  Anti-BGG 
-3  0§  o  o 
8  80  40  20 
12  1280  2000  640 
21  640  2000  640 
36  160  512  160 
3811 
42  8000 (8000)¶  4000 (2oo0)  2560 (256o) 
50  2000  1280  1280 
0 
80  (10) 
* Rabbits were given 100 mg BGG on days 2 and 5 of life. Bone marrow transfer was done 
in the 6th wk. 
Adult rabbits received 25 mg B GG intravenously 24 hr before sacrifice. 
§ Titers less than 10 are considered negative. 
It All rabbits received  10 mg HSA and 10 mg BGG intravenously. 
¶  Titers in parentheses after treatment of sera with 0.1 x~ 2-naercaptoethanol. NABIH  I. ABDOU  AND  MAXWELL  RICHTER  171 
It should be pointed out that only the antibodies formed in tolerant recipients 
given specifically primed bone marrow and antigen and reimmunized 38 days 
following primary immunization were mercaptoethanol-sensitive (Tables V and 
VI). The antibodies formed after secondary immunization in tolerant recipients 
of normal allogeneic bone marrow or in recipients of primed bone marrow im- 
munized with the non-cross-reacting antigen were all mercaptoethanol-resistant 
(Tables V and VI). 
TABLE VII 
Immune Response of HSA-Tolerant  Rabbits Given BGG-Primed or Normal  Allogeneic Bone 
Marrow and Immunized with HSA and BGG 
Hemagglufinafion titers of sera of HSA-tolerant rabbits* 
Day of bleeding after  given bone marrow from 
bone marrow transfer 
and  intravenous  adminis-  Normal donors  BGG-primed donors~ 
tration  of  lISA and BGG 
Anti-HSA  Anti-BGG  Anti-HSA  Anti-BGG 
--3  0§  0  0  0 
8  40  320  10  10 
12  1280  640  80  40 
21  320  80  40  40 
36  40  40  40  10 
3811 
42  1280  160  80  160 
50  320  80  20  40 
* Rabbits were given 100 mg HSA on days 2 and 5 of life. They were given normal or 
BGG-primed allogeneic bone marrow at 6 wk of age. 
Adult rabbits received 25 mg BGG intravenously 24 hr before sacrifice. 
§ Titers less than 10 are considered negative. 
[] All rabbits were given 10 mg HSA and 10 mg BGG intravenously. 
Rabbits made tolerant to HSA and given either normal or BGG-primed bone 
marrow cells  responded with antibody formation following immunization with 
either HSA or BGG (Table VII). Similarly,  good immune responses to both 
antigens  were  elicited  in  BGG-tolerant  rabbits  given  either  HSA-primed or 
normal bone marrow cells (Table VIII). In both cases,  brisk secondary immune 
responses were obtained after reimmunization of the rabbits 38 days following 
primary immunization (Tables VII and VIII). 
C. Immune Response to HSA  of Irradiated Rabbits Given Bone Marrow Cells 
from  Either HSA-Primed  or HSA-ToIerant  Rabbits.--Irradiated  rabbits  given 
HSA-primed or HSA-tolerant bone marrow failed to respond upon immuniza- 
tion with HSA, whereas irradiated recipients of normal allogeneic bone marrow 
cells responded well  (Table IX). 172  CELLS  INVOLVED IN  IM'MUNE RESPONSE.  XI 
TABLE VHI 
Immune Response of BGG-Tolerant Rabbits Given HSA-Primed or  Normal  Allogeneic Bone 
Marrow and Immunized  with BGG and HSA 
Day of bleeding  after 
bone marrow transfer 
and intravenous  adminis- 
tration of HSA and BGG 
Hemaggiutinatlon fiters of sera of BGG-tolerant 
rabbits* given bone marrow from 
Normal donors  HSA-primed  donors$ 
Anit-HSA  Anti-BGG  AntI-HSA  Anti-BGG 
--3  0§  0  0  0 
8  40  80  80  40 
12  80  320  160  320 
21  40  80  20  40 
36  10  80  0  0 
3811 
42  2000  640  640  1280 
50  1280  80  2560  1280 
*Rabbits were given 100 mg BGG on days 2 and  5 of life. They were given normal or 
HSA-primed allogeneic bone marrow at 6 wk of age. 
$ Adult rabbits received 25 mg HSA intravenously 24 hr before sacrifice. 
§ Titers less than 10 are considered negative. 
11 All rabbits were given 10 mg HSA and 10 mg BGG intravenously. 
TABLE IX 
Immune Response of Irradiated Rabbits Given Either Normal, HSA-Primed,  or HSA-Tolerant 
Allogeneic Bone Marrow and Immunized  with HSA 
Day of bleeding  after  Hemagglutination titers* of irradiated reclpients:~ 
bone marrow transfer  given bone marrow from 
and intravenous  adminis- 
tration of HSA  Normal donors  HSA-primed  donors§  HSA-tolerant  donors1[ 
7  20  0  0 
14  1280  0  0 
21  800  0  0 
28  320  0  20 
42  10  0  0 
* The antisera were incubated with HSA-sensitized sheep red cells. Titers less than 10 are 
considered negative. 
:~ Recipients were subjected to 800 R  total body irradiation followed by the intravenous 
administration of 5 X  108 bone marrow cells and 25 mg HSA. 
§ Donors were given 25 mg HSA intravenously 24 hr before sacrifice. 
[I Bone marrow obtained from 6 wk old rabbits which had been injected with  100  mg 
HSA on days 2 and 5 of life. 
DISCUSSION 
The present data strongly indicate that the cell which is unresponsive in the 
immunologically tolerant rabbit is  the antigen-reactive cell and not the anti- 
body-forming cell. This conclusion is based on the finding that, in the tolerant NABIIt  I.  ABDOU  AND  MAXWELL  RICHTER  173 
rabbit, antibody formation toward the tolerogenic antigen could be elicited if 
the recipients were given normal allogeneic bone marrow. This reconstitutive 
effect of the bone marrow, in an immunological sense, was found to be specific, 
since tolerant recipients of bone marrow obtained from donors primed with the 
tolerogenic antigen failed to form antibodies to this antigen but responded well 
after stimulation with a non-cross-reactive antigen. The specificity of the re- 
sponse  in  the  tolerant  recipient was  further demonstrated  by  the  fact  that 
recipients made tolerant to one antigen (i.e.  HSA)  and given allogeneic bone 
marrow cells from a donor primed with a different antigen (i.e. BGG) responded 
with  antibody formation when immunized with either of these two antigens. 
The  interpretation  of  the  latter  findings  is  that  the  antigen-reactive  cells 
directed to HSA, to which the tolerant recipient was made unresponsive, were 
present  in  the  transferred,  BGG-primed  bone  marrow,  and  therefore  the 
tolerant  recipient  could  successfully  mount  an  immune  response  to  HSA. 
Furthermore, the tolerant recipients of normal allogeneic bone marrow, follow- 
ing reimmunization 38 days after primary immunization, possessed circulating 
antibodies which could not be inactivated by mercaptoethanol, thus indicating 
that these antibodies were of a  "secondary" or 7S variety, and not of a  "pri- 
mary" or 19S type. On the other hand, the tolerant rabbits given primed bone 
marrow, which did not respond following initial administration of the antigen, 
produced  circulating  antibodies  after secondary immunization  38  days later 
which were all mercaptoethanol-sensitive; therefore these can be classified as 
"primary" or  19S-type antibodies.  Thus  one may conclude that  the latter, 
tolerant  recipients  were  indeed  tolerant  following  administration  of  primed 
bone marrow and antigen,  and that it was not simply a  matter of antibody 
having been synthesized but not detected by the techniques utilized. 
The present results, demonstrating that normal but not primed bone marrow 
could facilitate an immunological response of normal proportions in otherwise 
tolerant recipients, allow one to conclude that the cell which is immunologically 
unresponsive in the tolerant recipient is the antigen-reactive cell, which arises 
from cells normally residing in the bone marrow. The results also support the 
conclusion arrived at previously, based on investigations utilizing anti-allotype 
antisera  to  inhibit  the  formation  of  hemolytic  plaques  (5),  that  the  bone 
marrow contains only antigen-reactive cells and is devoid of antibody-forming 
cells. 
The data presented indicate that the immunocompetent cell (or cells) affected 
in the induction of the immunologically tolerant state in the neonate is probably 
identical  with  that  affected in  the  suppression  of  the  immune  response  by 
irradiation.  In the former case the antigen-reactive cell is made tolerant and 
therefore immunoincompetent,  and  in  the  latter  situation  it  is  the  antigen- 
reactive cell which is inactivated by the irradiation  (5). The antigen-reactive 
cell must be considered to have undergone some reaction(s) in the induction of 174  CELLS  INVOLVED  IN  IMMUNE  RESPONSE.  XI 
tolerance, since the bone marrow, following induction of the tolerant state, no 
longer possesses cells exhibiting antigen-reactive properties directed toward the 
tolerogenic antigen, similar to the "primed" bone marrow following induction of 
an immune response. The "tolerant marrow" therefore simulates the "primed 
marrow" with respect to its immunoincompetence in cell transfer experiments, 
although the mechanisms whereby immunoincompetence is induced in the bone 
marrow  in  these  two  diametrically  opposed  immune  states  are  probably 
different. The question may therefore be asked whether the antigen-reactive 
cell actually becomes tolerant and  remains  in  the  bone marrow in  an  unre- 
sponsive state,  or whether it persists as an antigen-reactive cell in some other 
organ in the tolerant rabbit, as distinct from the antibody-forming cell (char- 
acteristic of the primary response)  or the  memory cell  (characteristic  of the 
secondary immune  response).  Since it  has  been  demonstrated  that  antigen- 
reactive cells can interact with antigen in vitro and not be rendered tolerant or 
immunoincompetent (2), it is considered unlikely that interaction with  antigen 
in vivo would have induced a  tolerant state in this cell.  These questions are 
amenable  to  resolution  by  appropriate  cell  transfer  experiments  in  the 
laboratory. 
On  the basis  of the  data presented in  this  study and  of findings  reported 
previously from this laboratory (3  7),  one may state  unequivocally that  the 
bone marrow in the rabbit possesses only antigen-reactive cells and no antibody- 
forming cells. This interpretation begs the further assertion that, in the rabbit, 
the antibody-forming cells originate in lymphoid organs other than  the bone 
marrow and that their final "resting" site, following the intravenous administra- 
tion  of  the  antigen,  is  the  spleen  (5).  This  concept implies  the  existence of 
specific populations of bone marrow cells  committed or programed to interact 
with a site on the antigen molecule characterized by a unique molecular com- 
position  and configuration. How can this  interpretation be reconciled with  a 
pragmatic approach based on the deduction that there cannot exist more than 
just a small number of bone marrow antigen-reactive cells committed to react 
with any particalar antigen, in view of the large number of antigens known to 
exist (microbial, synthetic, haptenic, drugs, inanimate protein antigens, viruses, 
etc.)? The resolution of this dilemma rests on the probability that the above 
deductions are, in fact, correct but require qualification. The small number of 
antigen-reactive cells in  the  resting  state  directed  to  a  particular  antigen  is 
sufficient to mediate  the  immune  response,  in view of the  cells'  capacity to 
undergo explosive proliferation following interaction with the antigen. This has 
been demonstrated for the  thymic antigen-reactive cell in  the mouse  (9,  10) 
and the bone marrow antigen-reactive cell in the rabbit (6, 7). This prolifera- 
tive activity of the antigen-reactive cells in the rabbit takes place in an organ 
(or organs) other than the bone marrow, since the basal activity of the "primed" 
rabbit bone marrow cells in vitro is not higher than normal, resting levels (7). NABIH  I.  ABDOU  AND  MAXWELL  RICHTER  175 
Where do the antibody-forming cells  (AFC)  originate,  and  where do  they 
reside in the absence of antigenic stimulation? Attempts to resolve this problem 
are under way, and therefore one can only speculate. Since antibody formation 
can be elicited primarily in cells in the thymus (11), spleen (12-14), or draining 
lymph node (15-20), depending on the route of administration of the antigen 
(intrathymic, intravenous, and foot pad, respectively), it would appear that the 
potential AFC already reside in the lymphoid organs, and that the presence of 
antigen at these sites constitutes one of the determining factors concerned with 
the initiation of the local immune response. Recent findings (3-7) indicate that 
the committed antigen-reactive cells (ARC) vacate the bone marrow following 
FIG. 2.  Sources and destinations of antigen-reactive (ARC)  and antibody-forming (AFC) 
cells in the rabbit following intravenous administration of antigen. 
interaction with  the antigen  (activated antigen-reactive cells) and migrate to 
one or more of the lymphoid organs,  where they probably transfer activated 
antigen to the antibody-forming cells (Fig. 2). Interaction of these cells with the 
activated antigen results in their transformation into memory cells,  which are 
synonymous with Y  cells  (21)  or antigen-recognizing,  antibody-forming cells 
(22). The latter cells may, at this stage, be capable of forming, but not of re- 
leasing, humoral-type antibody, but they can be triggered to do so if stimulated 
by unprocessed or native antigen and are thereby transformed into actual anti- 
body-forming cells or Z cells (21, 23). Depending on the type and nature of the 
immunization, these latter cells will masquerade as either plasma cells (15-17, 
24-29) or lymphocytes (26, 30-36). 
It can also be argued that antigen-reactive cells must also, to a certain extent, 
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solely to the bone marrow, even in the resting, unimmunized state. It would be 
difficult to reconcile the concept of the bone marrow as the main source of anti- 
gen-reactive  cells  with  t'he  fact  that  primary  immune  responses  have  been 
achieved in vitro with  rabbit  lymph node and  spleen  fragments  (37-40)  and 
mouse spleen cells  (41-43). Actually, one may logically anticipate such a situa- 
tion, since the bone marrow is not a static assemblage of cells, but a fluid system 
with the cells free to enter the bloodstream. It is therefore likely that some anti- 
gen-reactive cells  will  always be vacating the bone marrow,  but  that  all  the 
antigen-reactive cells of the specific  clone,  and therefore of the same antigenic 
specificity, can be evicted from the bone marrow following the intentional injec- 
tion of a massive dose of the antigen. The scheme of cellular  interactions postu- 
lated in the induction of the primary immune response in the rabbit is presented 
in Table X  and Fig. 2. 
TABLE  X 
Cellular  Interactions Postulated in the Induction of the Primary Immune Response in the Rabbit 
1. Antigen +  macrophage  --+ 
2. Processed antigen +  antigen-reactive  --+ 
cell 
3. Activated  antigen  +  potential anti-  --+ 
body-forming  cell or X cell 
4. Memory cell +  native antigen 
processed antigen 
activated antigen 
memory cell or  antigen-recognizing, anti- 
body-forming  cell or Y cell 
antibody-forming  cell or Z cell 
Antibody 
The concept that a  multicdlular system (ARC and AFC)  exists  to provide 
for the immune response is based on findings in two animal species,  the rabbit 
and the mouse. The work in the rabbit is clear-cut. The bone marrow contains 
the cells which can interact with the antigen (ARC) (4, 6, 7), the manifestation 
of the  interaction  consisting of blastogenesis  and  mitosis  (proliferation),  but 
nol antibody formation. Although the organ of origin of the AFC in the rabbit 
has not yet been established, it is definitely not the bone marrow (5). Therefore, 
in the rabbit,  the terms ARC and AFC define exactly the functions intended: 
the interaction of the ARC with the antigen, leading to proliferation of the cells 
but not to antibody formation, and  the interaction of the AFC with what is 
probably an activated or processed antigen moiety to form humoral-type anti- 
bodies. A similar situation apparently exists  in the mouse, except that the thy- 
mus, not the bone marrow, possesses  the ARC. A number of investigators have 
reported  that  an  inmmne  response  can  be  elicited  in  an  irradiated  mouse 
provided that the mouse has been injected intravenously with isogenic  thymus 
and bone marrow cells  (44-47). Davies et al.  (9,  10) have observed that mouse 
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mediate an immune response  in an irradiated recipient.  Both Mitchell and 
Miller (44, 45, 47) and Taylor (48) have presented evidence strongly implicating 
the thymus as the source of the ARC in the mouse. Taylor (48) immunized 
mice with BSA, sacrificed them 24 hr later, and transferred their primed thymus 
cells, along with isogeneic normal bone marrow cells, to recipient  irradiated 
mice. The latter mice were incapable of eliciting an {mmune response following 
stimulation with BSA, whereas recipients of either normal isogeneic bone mar- 
row and thymus cells or primed isogeneic bone marrow cells and normal iso- 
geneic thymus cells could respond  (48). Results of a somewhat similar nature 
have been presented by Abdou and McKenna (49), who induced immunological 
tolerance  in mice to a  syngeneic spontaneous  mouse tumor and then trans- 
ferred thymus cells from these tolerant animals to 6 wk old mice which had been 
thymectomized at birth. These recipients were subsequently found to be toler- 
ant to the tumor antigens. Both Taylor (48) and Abdou and McKenna (49) 
speculated that the thymus cells had been made tolerant to the specific antigens 
prior to their transfer to the recipient mice. However,  results obtained in this 
laboratory indicate that a different interpretation must be considered. It has 
been observed that rabbit bone marrow ARC are not made tolerant following 
incubation, either in glass bead columns (2) or in suspension,  1 with relatively 
high concentrations of antigen, since these cells could then passively transfer 
immunocompetence to irradiated hosts with respect to the antigen(s) incubated. 
Thus, it is likely that the donor thymus of Taylor (48) and Abdou and McKelma 
(49) had been depleted of antigen-reactive cells, rather than made tolerant, 
after contact with antigen in vivo, in much the same manner as the rabbit bone 
marrow (1, 3, 6, 7) is depleted of ARC following the administration of the anti- 
gen. 
Sinclair and Elliot (50) have observed that the 6 wk old mouse thymectomized 
at birth is capable of responding to stimulation with sheep red blood cells, but 
that the dose of red cells required to stimulate an immune response is approxi- 
mately 100 times greater than that required to elicit a response of similar magni- 
tude in the normal or sham-operated  mouse. This observation suggests that the 
number of antigen-reactive cells in the mouse is reduced by a comparable figure 
(100-fold) in the thymectomized mouse, if one assumes a random interaction 
between the antigen and the antigen-reactive  cell in vivo. The data support the 
findings of other investigators (9, 10, 47) that the mouse thymus supplies anti- 
gen-reactive  cells, some of which may have seeded the other lymphoid organs 
prior to thymectomy but are markedly diminished  in number following thy- 
mectomy. If one assumes that no emigration of antigen-reactive cells from the 
thymus could have taken place prior to neonatal thymectomy,  it is necessary to 
postulate the existence of a second, if minor, source of antigen-reactive cells in 
the mouse.  In fact, evidence has been presented implicating the spleen as a 
1 Abdou, N. I., and M. Richter. Unpublished results. 178  CELLS  INVOLVED  IN  ~  RESPONSE.  XI 
source of antigen-reactive cells  in the mouse  (51-54).  Whether the antigen- 
reactive cells in the spleen are wholly endogenous to that organ, or whether 
they may have migrated to the spleen from the same organ which seeds the 
thymus with antigen-reactive ceils or their precursors in utero, cannot be as- 
certained at the present time. Thus, the thymus in the mouse serves as the 
counterpart of the bone marrow in the rabbit, insofar as the ARC is concerned. 
Recent observations by Mitchell and Miller (47) indicate that the bone marrow 
in the mouse is the source of the antibody-forming ce11, thus apparently com- 
pleting the circle in the mouse. 
The spleen, which can function as a hemopoietic organ in the mouse and rat 
(45,  55,  56),  can substitute for the combination of bone marrow and thymus 
cells in the transfer of immunocompetence to irradiated recipient mice (9, 46, 
51-54, 57). Furthermore, reversal of the postthymectomy wasting syndrome in 
the mouse can be achieved by the administration of spleen cells (58-60). Such 
reconstituted animals also regain the ability to reject  allogeneic skin grafts, 
indicating that the spleen in the mouse can exhibit thymic function as well. 
Therefore, the spleen in the mouse must contain both bone marrow-derived 
AFC and thymus-derived ARC, as well as other marrow- and thymus-derived 
cells.  In fact, an interaction between two types of cells present in the mouse 
spleen in the induction of hemolytic foci has been alluded to by Gregory and 
Lajtha (61), who observed that although the number of hemolytic loci found in 
the spleen of an irradiated mouse given isogeneic spleen cells increased linearly 
with respect to the number of spleen cells injected, the number of plaque-form- 
ing cells  (PFC)  increased allometrically with graft size. They (61)  speculated 
that, although the synthesis and release of antibody by the PFC can be attrib- 
uted to independent activities of individual cells,  the production of the PFC 
from precursors might be the result of an interaction between several cell types, 
one of which could be the antigen-reactive cell of thymic origin (9, 10, 47), which 
is present in the mouse spleen (58-60). Therefore, spleen cells cannot be used 
for the study of the sequence of cellular interactions in the immune response, 
since the ARC  and AFC are both small lymphocytes and cannot be distin- 
guished from each other on morphological grounds. 
Although the ARC and AFC, in the rabbit, have been shown to be irradia- 
tion-sensitive and irradiation-resistant, respectively (5), observations of a simi- 
lar nature have not yet been made for comparable cells in the rat or mouse. If the 
AFC and ARC in the latter animals should exhibit the same differential sensi- 
tivities to irradiation, a reevaluation of data obtained from investigations con- 
cerned with the transfer of immunocompetence with splenic cells to irradiated 
recipients would be in order to clarify which of the functional cell types, ARC or 
AFC, transfers the activity. 
One aspect of the problem, however, remains to be clarified. What criteria 
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preceding  discussion,  the  term  "antigen-reactive cell"  or  "antigen-sensitive 
cells" should be reserved only for those cells,  at least in the rabbit and the 
mouse, which react with the antigen but do not subsequently form antibodies. 
However,  some  investigators  concerned  with  elucidating  methods  for  the 
demonstration, recognition, and localization of ARC in the mouse have greatly 
confused the situation, since they have utilized the term ARC to designate cells 
in the spleen capable of inducing "hemolytic foci" (61-64)  or "bacterial im- 
mobilization in  gel"  (65,  66),  both  activities necessitating the mediation of 
antibodies. Armstrong and Diener (65) have stated that "the method is based 
on the belief that when these ARC are injected into a lethally irradiated host, 
they embed  in  the  spleen  in  predictable  concentrations and  respond  to  an 
antigenic stimulus by proliferating and differentiating into colonies of ARC." 
In  fact, they have stated categorically that the  success  of this technique is 
dependent  upon  antibody secreted  by the  "antigen-reactive cell."  Kennedy 
et al. (62, 63) have said that the interpretation of their results is predicated on 
"two postulated properties  of these cells: sensitivity to antigenic stimulation by 
sheep erythrocytes and ability to respond to this stimulation by proliferating to 
give rise to cells capable of hemolysin production." Playfair et al. (64) arrived 
at a similar conclusion. Such an interpretation is, at the very least, inconsistent 
with the definition of the term "antigen-reactive cell." In view of the fact that 
in both the rabbit (3-7) and the mouse (9, 10, 44-47) it has been demonstrated 
that ARC and AFC are independent cellular entities and do not differentiate one 
into the other, and since the mouse spleen has been shown to consist of a mix- 
ture of ARC and AFC (45, 46, 57-60),  the interpretations of Armstrong and 
Diener (65) and of Kennedy et al. (63) rest on tenuous grounds. 
In summary, the antibody-forming apparatus in the mouse has been shown 
to consist of two independent cellular compartments: the thymic ARC and the 
bone marrow AFC. In the rabbit, the bone marrow serves as the source of ARC; 
the organ of origin of the AFC has not as yet been defined. In both the rabbit 
and the mouse, the ARC appear to vacate the bone marrow and the thymus, 
respectively, after immunization or the induction of tolerance. The pathways 
taken by these cells in these two situations must be somewhat different, since 
the immune states which result are diametrically opposed.  Future investiga- 
tions  will  be  concerned  with  elucidating where,  as  well  as  the  mechanism 
whereby, the ARC transfer immunogenic information to the AFC in the im- 
munized animal, and why they fail to do so in the tolerant animal. The defect in 
the tolerant rabbit lies with the ARC, since the antibody-forming cell in this 
animal is fully capable of synthesizing humoral-type antibodies. 
SUMmArY 
Rabbits were made immunologically  tolerant to either human serum albumin 
or bovine gamma globulin by the neonatal administration of antigen. At 10 wk 180  CELLS  INVOLVED  IN  ~UNE  RESPONSE.  XI 
of age, they were challenged with the tolerogenic antigen and found to be non- 
responsive. However, these tolerant rabbits could respond with humoral anti- 
body formation directed  toward the tolerogenic antigen if they were  treated 
with normal, allogeneic bone marrow or bone marrow obtained from a  rabbit 
made tolerant toward a different antigen. They were incapable of responding if 
they were given bone marrow obtained from a rabbit previously made tolerant 
to the tolerogenic antigen. Irradiated rabbits were unable to respond if treated 
with tolerant bone marrow, but could respond well if given normal bone mar- 
row.  Since  it  has  previously been  demonstrated  that  the  antibody-forming 
cell, in an irradiated recipient of allogeneic bone marrow, is of recipient and not 
donor origin,  the data presented  strongly indicate that  the unresponsive cell 
in the immunologically tolerant rabbit is the antigen-reactive cell. 
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